keyword
https://read.qxmd.com/read/38598147/genetics-aspect-of-vitamin-c-ascorbic-acid-biosynthesis-and-signaling-pathways-in-fruits-and-vegetables-crops
#21
REVIEW
Adnan Sami, Shiming Han, Muhammad Zeshan Haider, Rameen Khizar, Qurban Ali, Muhammad Shafiq, Javaria Tabassum, Muhammad Nouman Khalid, Muhammad Arshad Javed, Mateen Sajid, Muhammad Aamir Manzoor, Irfan Ali Sabir
Vitamin C, also known as ascorbic acid, is an essential nutrient that plays a critical role in many physiological processes in plants and animals. In humans, vitamin C is an antioxidant, reducing agent, and cofactor in diverse chemical processes. The established role of vitamin C as an antioxidant in plants is well recognized. It neutralizes reactive oxygen species (ROS) that can cause damage to cells. Also, it plays an important role in recycling other antioxidants, such as vitamin E, which helps maintain the overall balance of the plant's antioxidant system...
April 10, 2024: Functional & Integrative Genomics
https://read.qxmd.com/read/38597173/risk-factors-for-recurrence-in-patients-with-hormone-receptor-positive-human-epidermal-growth-factor-receptor-2-negative-early-breast-cancer-in-japan-a-systematic-literature-review-and-meta-analysis
#22
REVIEW
Naoki Miyazaki, Toshiki Iwasaki, Hitomi Sakai, Rurina Watanuki, Yoshinori Tanizawa, Zhihong Cai, Tsutomu Kawaguchi, Junji Tsurutani, Kengo Nagashima
BACKGROUND: The clinicopathological factors indicating risk of recurrence are used to guide the choice of perioperative therapy in patients with breast cancer. Although several risk factors for recurrence have been reported in patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) early breast cancer in Japan, there has been no systematic review quantifying potential risk factors. METHODS: We performed a systematic literature review and meta-analysis using the MEDLINE, Embase, Cochrane CENTRAL, and Japan Medical Abstract Society databases to identify risk factors for recurrence in HR+/HER2- early breast cancer in Japan...
April 10, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/38595219/endocrine-responses-to-heated-resistance-exercise-in-men-and-women
#23
JOURNAL ARTICLE
J Luke Pryor, Daniel K Sweet, Paul Rosbrook, JianBo Qiao, David P Looney, Saleh Mahmood, Todd Rideout
Pryor, JL, Sweet, DK, Rosbrook, P, Qiao, J, Looney, DP, Mahmood, S, and Rideout, T. Endocrine responses to heated resistance exercise in men and women. J Strength Cond Res XX(X): 000-000, 2024-We examined the endocrine responses of 16 (female = 8) resistance trained volunteers to a single bout of whole-body high-volume load resistance exercise in hot (HOT; 40° C) and temperate (TEMP; 20° C) environmental conditions. Thermoregulatory and heart rate (HR) data were recorded, and venous blood was acquired before and after resistance exercise to assess serum anabolic and catabolic hormones...
April 9, 2024: Journal of Strength and Conditioning Research
https://read.qxmd.com/read/38594449/comprehensive-insights-into-the-impact-of-bacterial-indole-3-acetic-acid-on-sensory-preferences-in-drosophila-melanogaster
#24
JOURNAL ARTICLE
Raifa Abdul Aziz, Poornima Ramesh, Kokkarambath Vannadil Suchithra, Paul Stothard, Vanya Kadla Narayana, Shamprasad Varija Raghu, Fo-Ting Shen, Chiu-Chung Young, T S Keshava Prasad, Asif Hameed
Several bacteria of environmental and clinical origins, including some human-associated strains secrete a cross-kingdom signaling molecule indole-3-acetic acid (IAA). IAA is a tryptophan (trp) derivative mainly known for regulating plant growth and development as a hormone. However, the nutritional sources that boost IAA secretion in bacteria and the impact of secreted IAA on non-plant eukaryotic hosts remained less explored. Here, we demonstrate significant trp-dependent IAA production in Pseudomonas juntendi NEEL19 when provided with ethanol as a carbon source in liquid cultures...
April 9, 2024: Scientific Reports
https://read.qxmd.com/read/38591872/capsiate-ameliorates-secondary-hyperparathyroidism-by-improving-insulin-sensitivity-and-inhibiting-angiogenesis
#25
JOURNAL ARTICLE
Peiting Li, Jianda Zhou, Tianyin Wang, Jun Li, Wei Wu
Secondary hyperparathyroidism has a significant impact on the overall well-being of the body. Capsiates, known for their antioxidant and metabolic properties, have emerged as a promising alternative treatment for secondary hyperparathyroidism. This study aims to evaluate the effects and mechanisms of capsiates in the treatment of secondary hyperparathyroidism. To achieve our research objectives, we conducted a study on patients' serum and examined changes in metabolic markers using serum metabolomics. We induced secondary hyperparathyroidism in rat through dietary intervention and divided them into four groups...
April 2024: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/38590823/evaluating-the-safety-and-efficacy-of-cryopreserved-ovarian-tissue-transplantation-in-leukemia-patients-with-different-bone-marrow-remission-status-using-xenotransplantation
#26
JOURNAL ARTICLE
Yanqiu Li, Xiangyan Ruan, Muqing Gu, Juan Du, Fengyu Jin, Jiaojiao Cheng, Yanglu Li, Lingling Jiang, Zecheng Wang, Yu Yang, Mingzhen Zhang, Alfred O Mueck
BACKGROUND: Leukemia patients undergoing cryopreserved ovarian tissue transplantation (OTT) may carry a high risk of disease induction. Measurable residual disease (MRD) in bone marrow is linked to an elevated risk of relapse. It is controversial whether leukemia patients must be allowed to achieve measurable residual disease negative (MRD-negative) status instead of measurable residual disease positive (MRD-positive) status before ovarian tissue cryopreservation (OTC). OBJECTIVE: To explore the safety and efficacy of OTT in acute leukemia patients with different MRD status by using xenotransplantation...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38589887/the-protein-composition-of-exosomes-released-by-prostate-cancer-cells-is-distinctly-regulated-by-androgen-receptor-antagonists-and-agonist-to-stimulate-growth-of-target-cells
#27
JOURNAL ARTICLE
Golnaz Atri Roozbahani, Miriam Kokal-Ribaudo, Mehdi Heidari Horestani, Thanakorn Pungsrinont, Aria Baniahmad
BACKGROUND: Prostate cancer (PCa) is a prevalent malignancy in men worldwide, ranking as the second leading cause of cancer-related death in Western countries. Various PCa hormone therapies, such as androgen receptor (AR)-antagonists or supraphysiological androgen level (SAL) reduce cancer cell proliferation. However, treated cells may influence the growth of neighboring cells through secreted exosomes in the tumor microenvironment (TME). Here, the change of protein content of exosomes secreted from PCa cells through treatment with different AR-antagonists or SAL has been analyzed...
April 8, 2024: Cell Communication and Signaling: CCS
https://read.qxmd.com/read/38588464/exploring-the-role-of-ghrh-antagonist-mia-602-in-overcoming-doxorubicin-resistance-in-acute-myeloid-leukemia
#28
JOURNAL ARTICLE
Simonetta I Gaumond, Rama Abdin, Joel Costoya, Andrew V Schally, Joaquin J Jimenez
Acute myeloid leukemia (AML) is characterized by the rapid proliferation of mutagenic hematopoietic progenitors in the bone marrow. Conventional therapies include chemotherapy and bone marrow stem cell transplantation; however, they are often associated with poor prognosis. Notably, growth hormone-releasing hormone (GHRH) receptor antagonist MIA-602 has been shown to impede the growth of various human cancer cell lines, including AML. This investigation examined the impact of MIA-602 as monotherapy and in combination with Doxorubicin on three Doxorubicin-resistant AML cell lines, KG-1A, U-937, and K-562...
April 8, 2024: Oncotarget
https://read.qxmd.com/read/38585767/characterization-of-a-cytokinin-binding-protein-locus-in-mycobacterium-tuberculosis
#29
Jin Hee Yoo, Cristina Santarossa, Audrey Thomas, Damian Ekiert, K Heran Darwin
UNLABELLED: Cytokinins are adenine-based hormones that have been well-characterized in plants but are also made by bacteria, including the human-exclusive pathogen Mycobacterium tuberculosis . In M. tuberculosis , cytokinins activate transcription of an operon that affects the bacterial cell envelope. In plants, cytokinins are broken down by dedicated enzymes called cytokinin oxidases into adenine and various aldehydes. In proteasome degradation-deficient M. tuberculosis , the cytokinin-producing enzyme Log accumulates, resulting in the buildup of at least one cytokinin-associated aldehyde...
March 26, 2024: bioRxiv
https://read.qxmd.com/read/38582946/impact-of-different-growth-hormone-levels-on-gut-microbiota-and-metabolism-in-short-stature
#30
JOURNAL ARTICLE
Lan Li, Yu Wang, Yinyin Huang, Yi Lu, Weiyi Wang, Xian Chen, Xiaoou Shan, Hongchang Gao, Zhihan Yan
BACKGROUND: Growth hormone deficiency(GHD) and idiopathic short stature(ISS) are the primary causes of short stature in children. Animal experiments have revealed a link between growth hormone(GH), gut microbiota and metabolism, however, limited information is available from human trials. METHODS: Fecal samples collected from GHD (n = 36), ISS (n = 32) and healthy control (HC) children(n = 16) were subjected to microbiome (16 S rRNA gene sequencing) and metabolome (nuclear magnetic resonance,NMR) analyses...
April 6, 2024: Pediatric Research
https://read.qxmd.com/read/38582875/neoadjuvant-pertuzumab-plus-trastuzumab-in-combination-with-chemotherapy-for-human-epidermal-growth-factor-receptor-2-positive-breast-cancer-a-real-world-retrospective-single-institutional-study-in-china
#31
JOURNAL ARTICLE
Dong-Mei Peng, Juan Li, Jia-Xin Qiu, Lin Zhao
INTRODUCTION: Real-world studies on neoadjuvant dual anti-HER2 therapy combined with chemotherapy for breast cancer (BC) are scarce in China. This study aimed to evaluate the efficacy and safety of neoadjuvant dual anti-HER2 therapy combined with chemotherapy in a real-world setting. Moreover, differences in estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and proliferation cell nuclear antigen (Ki-67) expression pre- and post-neoadjuvant therapy were analyzed...
April 6, 2024: World Journal of Surgical Oncology
https://read.qxmd.com/read/38582092/3-year-invasive-disease-free-survival-with-chemotherapy-de-escalation-using-an-18-f-fdg-pet-based-pathological-complete-response-adapted-strategy-in-her2-positive-early-breast-cancer-phergain-a-randomised-open-label-phase-2-trial
#32
JOURNAL ARTICLE
José Manuel Pérez-García, Javier Cortés, Manuel Ruiz-Borrego, Marco Colleoni, Agostina Stradella, Begoña Bermejo, Florence Dalenc, Santiago Escrivá-de-Romaní, Lourdes Calvo Martínez, Nuria Ribelles, Frederik Marmé, Alfonso Cortés, Cinta Albacar, Geraldine Gebhart, Aleix Prat, Khaldoun Kerrou, Peter Schmid, Sofia Braga, Serena Di Cosimo, Maria Gion, Gabriele Antonarelli, Crina Popa, Emilia Szostak, Daniel Alcalá-López, Petra Gener, Jose Rodríguez-Morató, Leonardo Mina, Miguel Sampayo-Cordero, Antonio Llombart-Cussac
BACKGROUND: PHERGain was designed to assess the feasibility, safety, and efficacy of a chemotherapy-free treatment based on a dual human epidermal growth factor receptor 2 (HER2) blockade with trastuzumab and pertuzumab in patients with HER2-positive early breast cancer (EBC). It used an 18 fluorine-fluorodeoxyglucose-PET-based, pathological complete response (pCR)-adapted strategy. METHODS: PHERGain was a randomised, open-label, phase 2 trial that took place in 45 hospitals in seven European countries...
April 3, 2024: Lancet
https://read.qxmd.com/read/38581019/mesenchymal-stromal-cell-chondrogenesis-under-alk1-2-3-specific-bmp-inhibition-a-revision-of-the-prohypertrophic-signalling-network-concept
#33
JOURNAL ARTICLE
Solvig Diederichs, Simon I Dreher, Sarah Anna Nüesch, Sven Schmidt, Christian Merle, Wiltrud Richter
BACKGROUND: In vitro chondrogenesis of mesenchymal stromal cells (MSCs) driven by the essential chondro-inducer transforming growth factor (TGF)-β is instable and yields undesired hypertrophic cartilage predisposed to bone formation in vivo. TGF-β can non-canonically activate bone morphogenetic protein-associated ALK1/2/3 receptors. These have been accused of driving hypertrophic MSC misdifferentiation, but data remained conflicting. We here tested the antihypertrophic capacity of two highly specific ALK1/2/3 inhibitors - compound A (CompA) and LDN-212854 (LDN21) - in order to reveal potential prohypertrophic contributions of these BMP/non-canonical TGF-β receptors during MSC in vitro chondrogenesis...
April 5, 2024: Stem Cell Research & Therapy
https://read.qxmd.com/read/38580842/glucose-regulatory-hormones-and-growth-in-very-preterm-infants-fed-fortified-human-milk
#34
JOURNAL ARTICLE
Kristine Holgersen, Martin Bo Rasmussen, Itay Zamir, Lise Aunsholt, Gitte Zachariassen, Per Torp Sangild
BACKGROUND: Bovine colostrum (BC) contains a range of milk bioactive components, and it is unknown how human milk fortification with BC affects glucose-regulatory hormones in very preterm infants (VPIs). This study aimed to investigate the associations between hormone concentrations and fortification type, birth weight (appropriate/small for gestational age, AGA/SGA), milk intake, postnatal age, and body growth. METHODS: 225 VPIs were randomized to fortification with BC or conventional fortifier (CF)...
April 5, 2024: Pediatric Research
https://read.qxmd.com/read/38580580/the-efficacy-of-therapeutic-interventions-on-paediatric-burn-patients-height-weight-body-composition-and-muscle-strength-a-systematic-review-and-meta-analysis
#35
JOURNAL ARTICLE
Maxime D Cuijpers, Martin G A Baartmans, Koen F M Joosten, Karolijn Dulfer, Paul P M van Zuijlen, Johannes C F Ket, Anouk Pijpe
OBJECTIVE: To evaluate the efficacy of therapeutic interventions on pediatric burn patients' height, weight, body composition, and muscle strength. METHODS: A systematic literature search was conducted in PubMed, Embase, and Web of Science up to March 2021. Eligible interventional studies reported metrics on the height, weight, body composition, or muscle strength of pediatric burn patients in a peer-reviewed journal. Meta-analyses were performed if ≥ 2 trials of clinical homogeneity reported on an outcome measure at the same time point post-burn...
March 11, 2024: Burns
https://read.qxmd.com/read/38578394/population-pharmacokinetics-of-sacituzumab-govitecan-in-patients-with-metastatic-triple-negative-breast-cancer-and-other-solid-tumors
#36
JOURNAL ARTICLE
Abhishek G Sathe, Indrajeet Singh, Pratap Singh, Paul M Diderichsen, Xiaohui Wang, Peter Chang, Atiya Taqui, See Phan, Sandhya Girish, Ahmed A Othman
BACKGROUND AND OBJECTIVE: Sacituzumab govitecan (SG) is an antibody-drug conjugate composed of an antibody with affinity for Trop-2 coupled to SN-38 via hydrolyzable linker. SG is approved for patients with metastatic triple-negative breast cancer (mTNBC) who have received two or more prior chemotherapies (at least one in a metastatic setting) and for patients with pretreated hormone receptor positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) metastatic breast cancer...
April 5, 2024: Clinical Pharmacokinetics
https://read.qxmd.com/read/38577882/clinical-efficacy-of-tumor-organoid-guided-cancer-therapy-for-locally-advanced-unresectable-or-metastatic-breast-cancer
#37
JOURNAL ARTICLE
Ying-Yi Lin, Hong-Fei Gao, Hong Li, Qiong Hu, Bo-le Du, Sheng Li, Fang-Ping Xu, Min-Yi Cheng, Jia-Chen Zou, Xing-Xing Zheng, Teng Zhu, Kun Wang
Patient-derived organoids (PDOs) may facilitate treatment selection. This retrospective cohort study evaluated the feasibility and clinical benefit of using PDOs to guide personalized treatment in metastatic breast cancer (MBC). Patients diagnosed with MBC were recruited between January 2019 and August 2022. PDOs were established and the efficacy of customized drug panels was determined by measuring cell mortality after drug exposure. Patients receiving organoid-guided treatment (OGT) were matched 1:2 by nearest neighbor propensity scores with patients receiving treatment of physician's choice (TPC)...
April 5, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38577520/loss-of-24-hydroxylated-catabolism-increases-calcitriol-and-fibroblast-growth-factor-23-and-alters-calcium-and-phosphate-metabolism-in-fetal-mice
#38
JOURNAL ARTICLE
David Bennin, Sarah A Hartery, Beth J Kirby, Alexandre S Maekawa, René St-Arnaud, Christopher S Kovacs
Calcitriol circulates at low levels in normal human and rodent fetuses, in part due to increased 24-hydroxylation of calcitriol and 25-hydroxyvitamin D by 24-hydroxylase (CYP24A1). Inactivating mutations of CYP24A1 cause high postnatal levels of calcitriol and the human condition of infantile hypercalcemia type 1, but whether the fetus is disturbed by the loss of CYP24A1 is unknown. We hypothesized that loss of Cyp24a1 in fetal mice will cause high calcitriol, hypercalcemia, and increased placental calcium transport...
May 2024: JBMR Plus
https://read.qxmd.com/read/38576283/genotypic-frequency-of-rh-cw-antigen-in-blood-donors-of-northern-pakistan
#39
JOURNAL ARTICLE
Sarah Fatimah, Asad Mahmood Abbasi, Ali Abbasi, Nargis Sabir, Rozina Ghani, Rehan Ahmed Khan Lodhi
OBJECTIVE: To determine the genotypic frequency of Rh Cw antigen in blood donors of Northern Pakistan. STUDY DESIGN: Descriptive cross-sectional study. Place and Duration of the Study: Department of Molecular Haematology, Armed Forces Institute of Transfusion (AFIT), Rawalpindi, Pakistan, from August 2022 to January 2023. METHODOLOGY: Blood donors were randomly selected. Venous blood samples were taken in K3-EDTA anticoagulant tubes. ABO and Rh D grouping were performed conventionally...
April 2024: Journal of the College of Physicians and Surgeons—Pakistan: JCPSP
https://read.qxmd.com/read/38573759/comparison-of-the-real-world-reporting-of-symptoms-and-well-being-for-the-her2-directed-trastuzumab-biosimilar-ogivri-with-registry-data-for-herceptin-in-the-treatment-of-breast-cancer-prospective-observational-study-ogipro-of-electronic-patient-reported-outcomes
#40
JOURNAL ARTICLE
Andreas Trojan, Sven Roth, Ziad Atassi, Michael Kiessling, Reinhard Zenhaeusern, Yannick Kadvany, Johannes Schumacher, Gerd A Kullak-Ublick, Matti Aapro, Alexandru Eniu
BACKGROUND: Trastuzumab has had a major impact on the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC). Anti-HER2 biosimilars such as Ogivri have demonstrated safety and clinical equivalence to trastuzumab (using Herceptin as the reference product) in clinical trials. To our knowledge, there has been no real-world report of the side effects and quality of life (QoL) in patients treated with biosimilars using electronic patient-reported outcomes (ePROs)...
April 4, 2024: JMIR Cancer
keyword
keyword
12009
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.